general information

Hosted by Trinity College Dublin, the 2016 International Cancer Conference is the 10th on the theme “New Frontiers in Personalised Cancer Care”. An outstanding group of international speakers will give talks on advances in Cancer Prevention, Immunotherapy, Surgical Oncology, Radiotherapy and Targeted Therapeutics.

The conference features a keynote Burkitt Lecture to be delivered by the 2016 Burkitt Medal Awardee, who will be honoured at the conference dinner held in Trinity’s magnificent Dining Hall.

The International Cancer Conference was established through a tripartite agreement developed in 1999 by the Departments of Health in Ireland and Northern Ireland and the US Administration. Trinity in association with St James’s Hospital Dublin continues to host this conference.  

WHO SHOULD ATTEND THE CONFERENCE

Health professionals, cancer clinicians and clinical scientists, scientists working in cancer, representatives of pharmaceutical companies involved in oncology, policy makers, post-doctoral researchers within medicine and science will benefit from participation in the conference.

CPD POINTS

The conference has been approved by the Royal College of Physicians of Ireland for 12 CPD credits. 1 CPD credit is equivalent to 1 hour of educational activity.







Event FAQs

By Plane
There is one major international airport in Dublin, situated approximately 10km north of the city centre.  Dublin is easily accessible from the UK, Continental Europe and the east and west coast of the USA.  

Access from Dublin Airport to Dublin City
There are a number of private and public bus services that operate from outside the airport arrivals terminal: Aircoach, a privately run bus service, operates between the airport and a number of city hotels and locations. www.aircoach.ie

Airlink (bus 747), operated by Dublin Bus, will bring you directly from the airport to Busaras, the central bus station, located in the city. www.dublinbus.ie

There are also a number of other public bus services operating between the airport and various destinations

By Ferry
It is also possible to get to Dublin by ferry via Hollyhead, Liverpool and Isle of Man ports in Britain. Dublin has two ferry terminals – Dublin Port, located in the city centre, is serviced by bus and Dun Laoghaire ferry terminal, south of the city, is easily reached by a 20 minute car or DART train journey.

Trinity College Dublin has preferential agreements (applicable to weekdays only, if available) with the following hotels close to the conference venue:

Trinity City Hotel  
Contact: Jacinta Collins
Email: reservations@trinitycityhotel.com
Phone: 353 (0) 1 6481000
Fax: 353 (0) 1 6481010
More Information
Address: Pearse Sreet,
Dublin 4
 
Clayton Hotel Cardiff Lane
Contact: Jane Forsyth
Email: jforsyth@claytonhotels.com
Phone: 353 (0) 1 6439500
Fax: 353 (0) 1 6439510
More Information
Address: Sir John Rogerson's Quay,
Dublin 2
 
O'Callaghan Hotels Dublin
Contact: Maria Lawlor/Jeremy O’Keeffe
Email: dublin.reservations@ocallaghanhotels.com
Phone: 353 (0) 1 6073900
Fax: 353 (0) 1 6615663
 
More Information
 
O'Callaghan Hotels has three
Mont Clare Hotel
Alexander Hotel
Davenport Hotel

Conference dinner is not included in the conference registration fee and needs to be booked separately.

The dress code for the dinner is business attire.




Contact details

Trinity College Dublin
Dublin 2
Ireland
Email: ocleryz@tcd.ie

programme

New Frontiers in Personalised Cancer Care

Stanley Quek Lecture Theatre, Trinity Biomedical Sciences Institute

Printable Programme (PDF 404 kB)

OCTOBER 17th

9.00 – 9.20        WELCOME ADDRESS AND CONFERENCE OPENING

 

SESSION 1:   ADVANCES IN CANCER PREVENTION
   
Chair: Professor Cara Martin, Assistant Professor in Molecular Pathology and Tumour Biology, Department of Pathology, The Coombe Women and Infants University Hospital & Trinity College Dublin
   
9.20                     Advances in Cancer Prevention
  Professor Elisabete Weiderpass, Professor of Medical and Cancer Epidemiology, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
   
9.50 New Opportunities for Personalised Cancer Prevention
  Professor Catherine Hayes, Associate Professor Public Health Medicine, Trinity College Dublin, Ireland
   
10.20 Short Talk: HPV Primary Screening Pilot Study
  Dr Christine White, Department of Histopathology, Trinity College Dublin, Dublin, Ireland and the Coombe Women and Infants University Hospital, Dublin, Ireland
   
10.35 Short Talk: Frequency of BRCA 1 and BRCA2 mutations in an unaffected Irish cohort
  Michael Farrell, CNS in Cancer Genetics, Clinical Cancer Genetics Department, Mater Private Hospital, Dublin
   
10.50 - 11.30 Coffee Break and Poster Viewing

 

SESSION 2:   ADVANCES IN CANCER IMMUNOTHERAPY
   
Chair: Professor Derek Doherty, Associate Professor and Head of Immunology, Trinity Translational Medicine Institute and St. James’s Hospital
   
11.30                     Enhancing the Efficacy of Cancer Immunotherapeutics and Vaccines Using Inhibitors of Immune Checkpoint and Treg Cells
  Professor Kingston Mills, Professor of Experimental Immunology, Head Immunology, Inflammation and Infection Research Theme, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
   
12.00 In Vivo Discovery of Novel Targets for Cancer Immunotherapy
  Professor Kai Wucherpfennig, Chair of the Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Professor, Neurology, Harvard Medical School, Boston, USA
   
12.30 Adoptive T cell Therapy for Cancer
  Dr David Gilham, Reader, Clinical and Experimental Immunotherapy Group, Institute of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, UK
   
13.00 Short Talk: Immunotherapy options for the obese cancer patient
  Dr Joanne Lysaght, Department of Surgery, Trinity Translational Medicine Institute, St. James’s Hospital
   
13.15 Short Talk: HLA-DR is an independent prognostic indicator of patient survival in oesophageal adenocarcinoma
  Dr Margaret Dunne, Department of Surgery, Trinity Translational Medicine Institute, St. James’s Hospital
   
13.30 - 14.20 Lunch and Poster Viewing

 

SESSION 3: ADVANCES IN SURGICAL ONCOLOGY
   
Chair: Professor John Reynolds, Head of Surgery and Consultant Surgeon, Trinity Translational Medicine Institute and St. James’s Hospital
   
14.20                     Robotic Thoracolaparoscpic Oesophagectomy for Esophageal Cancer
  Professor Richard van Hillegersberg, Gastrointestinal Oncologic Surgeon, University Medical Center Utrecht, The Netherlands
   
14.50 Quantitative Imaging as a Potential Biomarker of Outcome
  Professor William R. Jarnagin, Chief, Hepatopancreatobiliary Service, Benno C. Schmidt Chair in Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, USA
   
15.20 Molecular Staging of Oesophageal Cancer - Moving Beyond Shades of Purple

  Mr Christopher Peters, Clinical Senior Lecturer and Consultant Upper GI and General Surgeon, Imperial College London, UK
   
15.50 - 16.20 Coffee Break and Poster Viewing
   
16.20 Introduction of the 2016 Burkitt Medal Awardee
  Professor Owen Smith, CBE, Professor of Paediatric and Adolescent Medicine at University College Dublin and Consultant Paediatric Haematologist at Our Lady’s Children’s Hospital, Crumlin, Dublin, Honorary Regius Professor of Physic (1637) in the School of Medicine, Trinity College Dublin
   
16.30 Burkitt Lecture

Cancer Prevention: from Denis Burkitt to the Human Genome Project
Dr Paul Brennan, Head of the Genetics Section of the International Agency for Research on Cancer (IARC/WHO), Lyon, France

   
17.30 Reception
   
19.00 Conference Dinner in Trinity College Dining Hall and Presentation of the 2016 Burkitt Medal (for delegates registered for the dinner in advance)

18th OCTOBER

SESSION 4: ADVANCES IN RADIOTHERAPY
   
Chair: Professor Jacintha O’Sullivan, Associate Professor, Department of Surgery, Trinity Translational Medicine Institute, St. James’s Hospital
   
9.00                     Personalised in Situ Tumour Vaccination by Radiation and Immunotherapy
  Professor Sandra Demaria, Professor of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, USA
   
9.30 Novel Concepts of Clinical Research in Radiation Oncology
  Professor Philippe Lambin, Head of Department, Maastricht Radiation Oncology Lab, University of Maastricht, The Netherlands
   
10.00 Short Talk: A novel role for the complement cascade in chemoradiation therapy resistant oesophageal adenocarcinoma
  Dr Niamh Lynam Lennon, Department of Surgery, Trinity Translational Medicine Institute, St. James’s Hospital
   
10.15 - 10.45 Coffee Break and Poster Viewing

 

SESSION 5: ADVANCES IN TARGETED THERAPEUTICS/PRECISION MEDICINE
   
Chair: Professor Lorraine O’Driscoll, Associate Professor of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin
   
10.45                   Role of the Inflammasomes in Intestinal Inflammation
  Professor Gabriel Núñez, Paul de Kruif Professor, Department of Pathology, University of Michigan, Ann Arbor, USA
   
11.15 Precision Medicine in the Breast Cancer Arena: Insights from National and International Collaborative Networks
  Professor William Gallagher, Professor Cancer Biology, Director, Conway Institute, University College Dublin, Dublin, Ireland
   
11.45 Mapping the PTM Landscape in Health and Disease
  Dr Yifat Merbl, Department of Immunology, The Leonard and Carol Berall Career Development Chair, Weizmann Institute of Science, Israel
   
12.15 Short Talk: A novel digital pathological approach to definitively identify CTCS
  Dr Cathy Spillane, Department of Histopathology, Trinity College Dublin, Dublin,  Pathology Research, The Coombe Women & Infants University Hospital, Dublin,
The Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland
   
12.30 Short Talk:Extracellular Vesicle studies identify the potential diagnostic relevance of miR-134 as a biomarker for Triple Negative Breast Cancer and as a potential therapeutic option
  Ms Michelle Lowry, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin
   
12.45 Short Talk:Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies
  Dr Dania Movia, Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, and AMBER Centre, CRANN Institute, Trinity College Dublin, Dublin, Ireland
   
13.00 - 14.00 Lunch and Poster Viewing

 

SESSION 6: ACADEMIC CANCER CENTRES
   
Chair: Professor Paul Browne, Head of School of Medicine and Consultant Haematologist, Trinity Translational Medicine Institute and St. James’s Hospital
   
14.00                     The Role of Accredited Comprehensive Cancer Centres in the Drive for Personalised Cancer Care
  Mr Simon Oberst, Accreditation and Designation WG Chairperson of the OECI
   
14.40 Irish Perspective
  Professor John O’Leary, Chair of Pathology, Cancer Theme Leader, Trinity College Dublin
   
15.10 Awards for Best Proffered Papers and Posters
   
  Close of Conference
   
15.45 Reception

 

Speakers

Sandra Demaria
Professor Sandra Demaria
X
William Gallagher
Professor William Gallagher
X
Catherine Hayes
Professor Catherine Hayes
X

 

Chris Peters
Professor Chris Peters
X
William Jarnagin
Professor William R. Jarnagin
X
Philippe Lambin
Professor Philippe Lambin
X

 

Sandra Demaria
Dr Yifat Merbl
X
Kiingston-Mills
Professor Kingston Mills
X
Catherine Hayes
Professor Gabriel Nuñez
X

 

Kai Wucherpfennig
Professor Kai Wucherpfennig
X
Richard Van Hillegersberg
Professor Richard van Hillegersberg
X
Dr. Paul Brennan
Dr Paul Brennan
X
David Gilham
Dr David Gilham
X
Professor Elisabete Weiderpass
Professor Elisabete Weiderpass
X

 

Simon Oberst
Mr Simon Oberst
X

 

burkitt medal

Established in 2013, the Burkitt Medal is designed to recognise people with the integrity, compassion and dedication matching that of Denis Burkitt, a Trinity graduate, who is known for his discovery of Burkitt lymphoma. Nominees should demonstrate extraordinary achievement and advancement in the field of cancer internationally.

ABOUT DENIS PARSONS BURKITT

D Burkitt

Denis Parsons Burkitt (28 February 1911 – 23 March 1993), surgeon, was born in Enniskillen, County Fermanagh, Ireland. He was the son of James Parsons Burkitt, a civil engineer. Aged eleven Denis lost his right eye in an accident. He attended Portora Royal School in Enniskillen and Dean Close School, England. In 1929 he applied to Trinity College Dublin to study his father’s profession, engineering, despite a tutor writing to his father expressing doubts if Burkitt would be capable of earning a degree. During his first year at Trinity he joined Room 40, a small group of undergraduates, who met regularly for prayer and Bible study, and committed his life to Jesus Christ. His religious convictions would be a driving force for the rest of his life. Soon after his commitment to Christianity, he felt that God was calling him to devote his life to medicine. He changed his study to medicine and graduated with his MB on 5 July, 1935. After graduating from Trinity College Dublin he continued his surgical training and obtained Fellowship of the Royal College of Surgeons in Edinburgh in 1938. He went on to write his MD entitled ‘Spontaneous rupture of abdominal viscera’ in 1947.

While serving as a ship’s surgeon in 1938, Burkitt decided he would be a surgeon first and a missionary second and hoped to work with the Colonial Service in West Africa. During his five-year sojourn as an army surgeon during World War Two, he married Olive Mary Rogers, a trainee nurse he had met while working as the Resident Surgical Officer at the Prince of Wales Hospital in Plymouth. Denis and Olive had three daughters Judy Howard, Cas and Rachel.

Despite having his application to the Colonial Office being turned down on account of his loss of sight, Burkitt passed a medical and enlisted into the Royal Army Medical Corps. He was posted to a military hospital in Mombasa. Burkitt 'made two major contributions to medical science related to his experience in Africa.

The first was the description, distribution, and ultimately, the etiology of a pediatric cancer that bears his name Burkitt's lymphoma'. Burkitt in 1957 observed a child with swellings in the angles of the jaw.  Having an intensely enquiring mind, Burkitt took the details of these cases to the records department, which showed that jaw tumours were common, were often associated with other tumours at unusual sites in children in Uganda. He kept copious notes and 'concluded that these apparently different childhood cancers were all manifestations of a single, hitherto unrecognized tumour complex'. Burkitt published A sarcoma involving the jaws of African children. The newly identified cancer became known as 'Burkitt's lymphoma. He went on to map the geographical distribution of the tumour. Burkitt, together with Dr Dennis Wright, published a book titled 'Burkitt's Lymphoma' in April 1970.

His second major contribution came when, on his return to Britain, Burkitt compared the pattern of diseases in African hospitals with Western diseases. He concluded that many Western diseases which were rare in Africa were the result of diet and lifestyle. He wrote a book Don't Forget Fibre in your Diet, which was an international bestseller.

Although one study showed that people who eat very low levels of fiber—less than 10 grams per day—had an 18 percent higher risk of colorectal cancer, the more general idea that colon cancer is a fiber deficiency disease is now generally considered incorrect by cancer researchers. Nevertheless, research suggests that a diet high in dietary fiber is advised as a precaution against other diseases such as heart disease and diabetes. He had an alternative theory, published in numerous articles and books, that the use of the natural squatting position for defecation protects the natives of Africa and Asia from gastrointestinal diseases. 

Burkitt was president of the Christian Medical Fellowship and wrote frequently on religious/medical themes. He received the Bower Award and Prize in 1992. He died on 23 March 1993 in Gloucester and was buried in Bisley, Gloucestershire, England.

CALL FOR NOMINATIONS FOR BURKITT AWARD 2017

Deadline for submissions – 1 March 2017

Completed forms to be returned to Professor Orla Sheils, Chair of the Selection Committee, by e-mail: CONFSM@tcd.ie   

General Information (PDF 407 kB)

Nomination Form (Ms Word 458 kB)



PAST BURKITT MEDAL AWARDEES

Burkitt Medal Awardee 2016 Paul Brennan, PhD

Paul Brennan is the Head of the Genetics Section of the International Agency for Research on Cancer (IARC), Lyon, France. IARC is the specialised cancer agency of the World Health Organization (WHO) with the objective to promote international collaboration in cancer research. Dr Brennan's primary area of work is conducting very large multi-partner studies that aim to use genetics to understand the causes of cancer. This is done by exploring the genome of individuals who develop cancer, in order to identify clues as to why they are more susceptible. It also involves investigating the genomes of the tumours, in order to identify what triggered the tumour in the first place. His group works with colleagues in many different parts of the world, with active studies underway in central and eastern Europe, central and south-east Asia, and Latin America. Among others, Dr Brennan has collaborators in Trinity College Dublin. Dr Brennan and his colleagues at IARC have made an outstanding contribution to promoting international collaboration in the study of cancer for the ultimate benefit of those affected by the disease.


Burkitt Medal Awardee 2015 Riccardo Dalla-Favera, MD, MSc

Riccardo Dalla-Favera is Professor of Pathology & Cell Biology and Director, Institute for Cancer Genetics at Columbia University, New York, USA. Professor Dalla-Favera’s career started with his pioneering work on the cloning and chromosomal mapping of human proto-oncogenes, including c-MYC. This work established the basis for the seminal work on the involvement of c-MYC in chromosomal translocations in Burkitt’s lymphoma. His research has continued to yield new insights into the pathogenesis of human B cell lymphomas, and, in particular, on the identification of the genetic lesions and biological mechanisms responsible for the development of these diseases.



Burkitt Medal Awardee 2014John L. Ziegler, MD, MSc

John Ziegler, Founding Director, Global Health Sciences Graduate Program University of California San Francisco (UCSF), USA, received his undergraduate degree (BA, English Literature) from Amherst College, Amherst Massachusetts, and his MD from Cornell University Medical School in New York City. Following medical house staff training at Bellevue Hospital in New York, he joined the National Cancer Institute (NCI) in 1966, beginning a life-long career in cancer research and care. In 1967 he was assigned to begin a long collaboration with Makerere University in Kampala, Uganda, studying Burkitt’s lymphoma and other indigenous cancers. Together with Ugandan counterparts, he developed curative therapies for lymphoma and established a cancer institute that today has expanded to a major center of excellence in sub Saharan Africa. After five years Ziegler returned to NCI to head clinical oncology, and in 1981 moved to UCSF. The AIDS pandemic made its first appearance in San Francisco, heralded by opportunistic infections and two malignancies – Kaposi’s sarcoma and non Hodgkin’s lymphoma. Ziegler and colleagues made important contributions to this field both in California and back in Uganda. In his later career, earning an MSc in epidemiology from the London School of Hygiene and Tropical Medicine, Ziegler headed a cancer genetics clinic at UCSF, and most recently was founding director of a global health Master’s degree.



Burkitt Medal Awardee 2013Murray F. Brennan, MD

Born in Auckland, New Zealand, Dr. Murray Brennan received a degree in mathematics from the University of New Zealand and a medical degree from the University of Otago in 1964. In 1970 he worked at Peter Bent Brigham Hospital, Harvard Medical School, and at the Joslin Research Laboratories. After residency at the Brigham, Dr. Brennan joined the National Cancer Institute. In 1981, he joined Memorial Sloan-Kettering Cancer Center (MSKCC) as Chief of Gastric and Mixed Tumor Service. Dr. Brennan was Chairman of the Department of Surgery at MSKCC from 1985 until June of 2006. He currently holds the Benno C. Schmidt Chair in Clinical Oncology and is Director of the International Center and Vice President for International Programs at MSKCC. He has lectured throughout the world and authored and co-authored more than 1,000 scientific papers and book chapters focusing on surgical oncology, endocrinology, metabolism, and nutrition, and is the author of a book on soft tissue sarcoma. Dr Brennan received numerous honours for his contribution to oncology. Dr. Brennan’s interest, in addition to patient care and research, has been the development of young surgeons. 

 

Registration

Consultant/PI/Industry €200
Post-doctoral/registrar €150
Student/nurses €50

The registration fee includes morning coffee, lunch, afternoon tea, reception on both days of the conference.

Conference dinner in Trinity College Dining Hall is €50 (additional to the registration fee).

You can register here

 

Abstracts

To submit abstracts visit http://www.bytesizedhost.co.uk/tcdc/.

Please note that abstract submissions will close on the 1st of September.

Partners

abbvie
novartis
genomic

If you are interested in sponsoring the 2016 International Cancer Conference, please contact:
Zhanna O’Clery
Tel: 00353 1 896 2560
Email: ocleryz@tcd.ie